Small Molecule Pan-Dengue and West Nile Virus NS3 Protease Inhibitors

Abstract

This class of compounds is the first to demonstrate competitive pan-dengue and WNV NS3 protease inhibition and, given the sequence conservation among flavivirus NS3 proteins, suggests that developing a pan-dengue or possibly pan-flavivirus therapeutic is feasible.